<qa>  What is TRV130?Patients with moderate to severe pain caused by medical conditions or surgery, who require IV opioid therapy may be enrolled in this open label safety study. Patients will be treated with TRV130 by IV bolus, PCA patient-controlled analgesia administration, or both, as determined by the investigator, for a duration not to exceed 14 days. 